A commentary on 'Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study'

Int J Surg. 2024 Feb 1;110(2):1294-1295. doi: 10.1097/JS9.0000000000000891.

Authors

Xin Zhao¹, Tianyang Mao¹, Qingyun Xie¹, Fengwei Gao², Hong Wu²

Affiliations

¹ Department of Hepato-Pancreato-Biliary Surgery, The People's Hospital of Leshan, Leshan.
² Liver Transplantation Center, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, People's Republic of China.

No abstract available

Publication types

Multicenter Study

MeSH terms

Carcinoma, Hepatocellular* / pathology
Carcinoma, Hepatocellular* / surgery
Chemoembolization, Therapeutic* / adverse effects
Cohort Studies
Humans
Liver Neoplasms* / pathology
Liver Neoplasms* / surgery
Retrospective Studies
Treatment Outcome